You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Baxter
McKinsey
Dow
Merck

Last Updated: September 26, 2020

DrugPatentWatch Database Preview

Litigation Details for Plexxikon Inc. v. Novartis Pharmaceuticals Corporation (N.D. Cal. 2017)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Plexxikon Inc. v. Novartis Pharmaceuticals Corporation (N.D. Cal. 2017)

Docket   Start Trial Date Filed 2017-08-03
Court District Court, N.D. California Date Terminated
Cause 35:271 Patent Infringement Assigned To Haywood Stirling Gilliam Jr.
Jury Demand Plaintiff Referred To
Parties GLAXOSMITHKLINE LLC; GLAXOSMITHKLINE PLC; NOVARTIS PHARMACEUTICALS CORPORATION; PLEXXIKON INC.
Patents 10,011,645; 10,012,654; 10,022,509; 10,023,621; 10,066,017; 10,472,599; 10,509,043; 6,004,596; 6,028,071; 6,071,510; 6,565,870; 6,620,942; 6,867,005; 6,942,165; 7,012,066; 7,056,867; 7,090,599; 7,598,089; 7,871,598; 7,967,704; 8,012,472; 8,048,043; 8,057,998; 8,071,137; 8,071,565; 8,071,579; 8,071,645; 8,101,564; 8,227,509; 8,317,640; 8,595,165; 8,597,654; 8,598,227; 8,598,998; 8,702,654; 9,005,599; 9,018,204; 9,018,243; 9,051,565; 9,057,072; 9,063,151; 9,066,942; 9,090,558; 9,149,579; 9,150,645; 9,227,031; 9,243,025; 9,422,558; 9,422,564; 9,539,341; 9,579,421; 9,598,422; 9,844,509; 9,844,510; 9,844,558; 9,849,099
Attorneys Andrew R Basile; Clement S. Roberts; Daralyn J. Durie; David Floyd McGowan; David Mlaver; Eddie Dean Woodworth; Eugene Novikov; Ian Barnett Brooks; Jeffrey D. Wilson; Jennifer Butler Routh; Katherine Nicole Clouse; Laura Elizabeth Miller; Matthew Walter Samuels; Michael S. Nadel; Nathanael R Luman; Paul M. Schoenhard; Raghav R. Krishnapriyan; Ryan T McCleary; Stephen J Elkind; Thomas P. Steindler; Victoria Leigh Weatherford; William G. Gaede , III; William Rolland Zimmerman
Firms Durie Tangri LLP; Knobbe Martens Olson & Bear, LLP; Knobbe Martens Olson and Bear; McDermott Will & Emery LLP; McDermott Will and Emery LLP; McDermott Will Emery LLp, the McDermott Building; Orrick Herrington and Sutcliffe LLP; Young Basile Hanlon and MacFarlane, P.C.; Young Basile Hanlon MacFarlane, P.C.
Link to Docket External link to docket
Small Molecule Drugs cited in Plexxikon Inc. v. Novartis Pharmaceuticals Corporation

Details for Plexxikon Inc. v. Novartis Pharmaceuticals Corporation (N.D. Cal. 2017)

Date Filed Document No. Description Snippet Link To Document
2020-05-08 421 Order on Motion for Miscellaneous Relief announced by a patent law expert witness”)). As an initial 6 matter, … conclusions that U.S. Patent Nos. 9,469,640 (the ’640 Patent) and U.S. Patent No. 9,844,539 (the … 18 discipline.” Primiano, 598 F.3d at 565. To ensure reliability, the Court “assess[es] the… 14 Cooper v. Brown, 510 F.3d 870, 942 (9th Cir. 2007); see also Primiano v. Cook, … 23 ’539 Patent) are invalid, anticipated, and obvious and lack written External link to document
2020-05-26 422 Order on Motion for Miscellaneous Relief 7 States v. Sandoval-Mendoza, 472 F.3d 645, 654 (9th Cir. 2006). The jury will ultimately have… 10 11 … 3 August 2017 4:17-cv-04405-HSG Patent Plaintiff District Court, N.D. California…Re: Dkt. No. 204 11 …See id. at ¶ 72. 11 Dr. Ortiz-Urda then offers two primary opinions External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Baxter
Johnson and Johnson
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.